Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions. (Q48399270)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 August 2012

Language	Label	Description	Also known as
English	Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.	scientific article published on 22 August 2012

Statements

scholarly article

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions. (English)

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

N Rampersaud

1

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

A Harkavyi

2

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

G Giordano

3

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

R Lever

4

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

J Whitton

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

P S Whitton

6

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

publication date

22 August 2012

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

46

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

5

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

183-193

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein

1 reference

https://opencitations.net/index/coci/api/v1/citations/10.1073/PNAS.0409713102

30 October 2021

Procedural learning and neostriatal dysfunction in man.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Serotonergic dysfunction in Parkinson's disease and its relevance to disability.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Noradrenergic activation of the basolateral amygdala modulates consolidation of object recognition memory

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Frontal lobe dysfunction in secondary depression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disea

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Pre-training to find a hidden platform in the Morris water maze can compensate for a deficit to find a cued platform in a rat model of Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Is immobility of rats in the forced swim test "behavioral despair"?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Tryptophan depletion impairs object-recognition memory in the rat: reversal by risperidone

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Non-motor dysfunction in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

PET imaging of neocortical monoaminergic terminals in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Reduced levels of norepinephrine transporters in the locus coeruleus in major depression.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

The neuropathological basis for depression in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Acute and chronic effects of 4-chloroamphetamine on monoamine metabolism in the rat brain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Noradrenaline and Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Prolonged activation of cAMP-response element-binding protein and ATF-2 needed for nicotine-triggered elevation of tyrosine hydroxylase gene transcription in PC12 cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Depression in Parkinson's disease -- a review

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Cognitive deficits in the early stages of Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Central serotonin depletion affects rat brain areas differently: a qualitative and quantitative comparison between different treatment schemes

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Differential age-related loss of pigmented locus coeruleus neurons in suicides, alcoholics, and alcoholic suicides.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Glucagon-like peptide-1-responsive catecholamine neurons in the area postrema link peripheral glucagon-like peptide-1 with central autonomic control sites.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Early diagnosis of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Tyrosine hydroxylase phosphorylation: regulation and consequences

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Parkinson's disease: mechanisms and models

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Emotion circuits in the brain

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

A systematic review of depression and mental illness preceding Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Disease model: Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Non-motor symptoms of Parkinson's disease: diagnosis and management

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Cortical networks of procedural learning: evidence from cerebellar damage

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Does the behavioral "despair" test measure "despair"?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Long-term regulation of serotonergic activity in the rat brain via activation of protein kinase A.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Role of norepinephrine in the pathophysiology and treatment of mood disorders

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Norepinephrine: The redheaded stepchild of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Influence of noradrenaline denervation on MPTP-induced deficits in mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Positron emission tomography of striatal serotonin transporters in Parkinson disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Spared caudal brainstem SERT binding in early Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Learning and memory functions of the Basal Ganglia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo(1)H-MRS study at 9.4T.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

The premotor phase of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Brain serotonin transporter binding in non-depressed patients with Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Caffeine prevents disruption of memory consolidation in the inhibitory avoidance and novel object recognition tasks by scopolamine in adult mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

SSRIs in the treatment of depression in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Non-motor symptoms in Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Behavioural despair in rats: A new model sensitive to antidepressant treatments

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Depression research: where are we now?

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Rasagiline improves learning and memory in young healthy rats

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Etiology and pathogenesis of Parkinson's disease

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Increased risk of Parkinson's disease after depression: a retrospective cohort study

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

A new Alzheimer's disease interventive strategy: GLP-1.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1016/J.NPEP.2012.07.004

Identifiers

10.1016/J.NPEP.2012.07.004

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

1 reference

Europe PubMed Central

11 February 2018

http://europepmc.org/abstract/MED/22921965

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48399270&oldid=2043416152"